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Abstract
We examined the cytotoxic effects of chaetocin on clear cell renal cell
carcinoma (ccRCC) cells and the possibility to combine the effects of
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chaetocin with the effects of cytokine-induced killer cells (CIK) assayed
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Schmidt-Wolf1
by MTT assay and FACS analysis. Chaetocin is a thiodioxopiperazine
produced by fungi belonging to the chaetomiaceae family. In 2007, it
was first reported that chaetocin shows potent and selective ex vivo
anti-cancer activity by inducing reactive oxygen species. CIK cells are
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generated from CD3+/CD56- T lymphocytes with double negative
CD4-/CD8- phenotype that are isolated from human blood. The addition
of distinct interleukins and antibodies results in the generation of CIK
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cells that are able to specifically target and destroy renal carcinoma
cells. The results of this research state that the anti-ccRCC activity of
chaetocin is weak and does not show a high grade of selectivity on clear
cell renal cell carcinoma cells. Although the CIK cells show a high grade
of selective anti-ccRCC activity, this effect could not be improved by the
addition of chaetocin. So chaetocin seems to be no suitable agent for
specific targeting ccRCC cells or for the combination therapy with CIK
cells in renal cancer.
Keywords: clear cell renal cell carcinoma, chaetocin, cytokine-induced
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Zusammenfassung
Wir untersuchten die zytotoxischen Effekte von Chaetocin auf Zellen
von klarzelligem Nierenzellkarzinom (ccRCC) und die Möglichkeit, die
Effekte von Chaetocin mit den Effekten von Zytokin-induzierten Killer-
zellen (CIK) zu kombinieren mit Hilfe von MTT Assay und FACS-Analyse.
Chaetocin ist ein Thiodioxopiperazin hergestellt von Pilzen aus der Fa-
milie der Chaetomiaceae. In 2007 wurde erstmals berichtet, dass
Chaetocin potente und selektive ex vivo Anti-Krebs-Aktivität durch Indu-
zierung von reaktivem Sauerstoff besitzt. CIK-Zellen wurden aus
CD3+/CD56- T-Lymphozyten aus menschlichem Blut hergestellt mit
negativem CD4-/CD8- Phänotyp. Die Addition von bestimmten Interleu-
kinen und Antikörpern führte zu der Herstellung von CIK-Zellen mit
spezifischer Ausrichtung auf Nierenzellkarzinomzellen. Die Ergebnisse
besagen, dass die anti-ccRCC Aktivität von Chaetocin schwach ist und
keinen hohen Grad an Selektivität bzgl. klarzelligen Nierenzellkarzinom-
zellen besitzen. Obwohl CIK-Zellen einen hohen Grad an selektiver anti-
ccRCC Aktivität besitzen, konnte dieser Effekt nicht durch die Zugabe
von Chaetocin gesteigert werden. Daher erscheint Chaetocin keine ge-
eignete Substanz für ein spezifisches Targeting von ccRCC-Zellen oder
für die Kombinationstherapie mit CIK-Zellen beim Nierenzellkarzinom
zu sein.
Schlüsselwörter: klarzelliges Nierenzellkarzinom, Chaetocin,
Zytokin-induzierte Killerzellen, CIK-Zellen
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Introduction
There are threemajor types of renal cell carcinoma (RCC).
The most common types are clear cell renal cell car-
cinoma (ccRCC) (80–90%), papillary renal cell carcinoma
(10–15%) and chromophobe renal cell carcinoma (3–5%)
[1], [2].
Mutations of the epithelial cells lining the proximal tubule
of the nephrons of the kidney are thought to give rise to
RCC [3].
A suitable medical agent should be able to not only de-
crease the RCC growth but also kill specific cancerous
cells without causing high casualties among non-cancer-
ous cells. A promising new agent for targeting tumor cells
is chaetocin.
Chaetocin was found to have a potent and selective ex
vivo cytotoxic activity against different cancerous cell
lines, however, the exact mechanism of its cytotoxic ef-
fects are still not fully understood.
Most likely chaetocin is taken up by glutathione receptors
followed by accumulation inside the cells. Hereby the
drug accumulates in non-cancerous as well as in cancer-
ous cells while the cytotoxic effects weremainly observed
in cancerous cells. After the accumulation inside the cells
chaetocin is thought to induce reactive oxygen species
(ROS) that then kill the cancerous cells via oxidative stress
but mostly spare the non-cancerous cells because they
counter the oxidative stress with different enzymatic
systems [4], [5]. The effects of chaetocin on cytokine-in-
duced killer (CIK) cells is examined as well in order to
determine if the CIK cells can be used along with
chaetocin for ccRCC treatment.
CIK cells are cytotoxic lymphocytes resulting from treat-
ment of peripheral bloodmononuclear cells (PBMCs) that
are isolated from whole blood and incubated with anti-
CD3-antibody (α-CD3), interferon human interleukin 2
(IL-2) and human interleukin 1β (IL-1β) [6]. The treatment
results in a new cell type with a unique receptor reper-
toire. CIK cells express the T-cell receptor CD3 as well as
the natural killer cell receptor NKG2D that is thought to
be responsible for the specific targeting of tumor cells
[7], [8]. This recognition system is unlike the T cell recept-
or complex MHC unrestricted and specific for tumor cells.
The mechanism behind the destruction of tumor cells is
still unknown besides the fact that CIK cells produce a
variety of cytokines that activate and influences other
immune effector cells nearby.
The aim of this thesis is to research the effects of
chaetocin on ccRCC in comparison to non-cancerous cells
and CIK cells in order to determine whether the medical
agent can be used solely or in combination with CIK cells
to increase the specific destruction of ccRCC cells while
sparing non-cancerous cells.
Material and methods
Cell lines and culture conditions
For the cultivation of A-498, CAKI-2 and CCD-18Co (DMSZ,
Braunschweig, Germany), 10ml RPMI 1640mediumwith
L-glutamine and 2.0 g l–1 sodium bicarbonate (NaHCO3)
(PAN BIOTECH, Aidenbach, Germany) containing 10%
fetal bovine serum (FBS) (Gibco Life Technologies,
Darmstadt Germany) and 100 U ml–1 penicillin and
streptomycin (P/S) (Life Technologies, Darmstadt Ger-
many) in a 75 cm2 culture flask was used. The cell lines
were passaged every third or fourth day and stored in an
incubator at 37°C in an atmosphere containing 95% air
and 5% CO2.
Passaging was done by using 2 to 3 ml trypsin-EDTA (1x)
(Gibco by Life Technologies, Darmstadt, Germany) after
washing the cells with PBS (1x) (phosphate-buffered sa-
line). Splitting in a ratio of 1/5 to 1/10 was done after
8 min centrifugation at 1800 rpm.
Cytokine-induced killer cell generation
The blood (donations from UKB) wasmixed with PBS (1x)
containing 1% bovine serum albumin (BSA) (Life Techno-
logies; PAA, Cölbe, Germany) and applied onto a Lympho-
prep density gradient medium (Pancoll) (PAN BIOTECH,
Aidenbach, Germany) in order to perform a density
gradient centrifugation at 1,000 rpm for 30 min without
breaks on. Afterwards the interphase containing the
lymphocytes was removed andwashed several times with
PBS/1% BSA followed by treatment with an Ery-Lysis-
Buffer. The extracted lymphocytes were then placed into
a culture flask containing 40 ml of the modified RPMI
medium and treated with 1,000 U ml–1 IFN-γ. One day
after the extraction 300 Uml–1 IL-2, 50 ngml–1 α-CD3 and
100 U ml–1 IL-1β were added to the cells. Every third day
half of the medium was exchanged and 300 U ml–1 IL-2
were added. The CIK cell generation is complete after
two weeks of maturation.
The generated Cytokine-induced killer cells were cultured
in RPMI 1640 medium with L-glutamine and 2.0 g l–1 So-
dium bicarbonate containing 10% FBS, 100 U ml–1 P/S
and 2.5% hepes. The CIK cells were stored under the
same conditions as ccRCC cells but were passaged every
three days followed by the addition of 300 U ml–1 human
interleukin 2 (IL-2).
Chaetocin preparation
Chaetocin (Santa Cruz Biotechnologie, Heidelberg, Ger-
many) was dissolved in high concentrations with DMSO.
The stock solution was kept at –20°C for a maximum of
one month. Prior to the experiments the stock solution
was diluted with the corresponding medium.
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Figure 1: Viability of tumor cell lines CAKI-2 (blue, left), A-498 (red, middle) and non-cancerous cell line CCD-18Co (green, right)
after 24 h of exposure to chaetocin concentration in the range of 0–10 nM determined with a micro plate reader after MTT
assay. Positive control; cell lines killed with DMSO. Negative control; cells without any treatment.
MTT assay
The cell lines were applied onto a 96-well plate with a
concentration of 1 * 105 cells ml–1 in the presence of
different chaetocin concentration in the range of 1 nm
to 400 nm.
The chaetocin was first solved in DMSO and afterwards
diluted within the corresponding RPMImedium. The cells
were then incubated for 1 to 4 days without further addi-
tion of chaetocin during the incubation.
After the incubation 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide solved in PBS (MTT reagent)
was added to the cells followed by another hour of incub-
ation.
TheMTT reagent was removed and the cells were treated
with DMSO to release the MTT reagent stored in the still
living cells. The absorption of the released MTT was then
measured with an ELISA-READER at 560 nM [9], [10].
FACS analysis
The cancerous and non-cancerous cell lines were incub-
ated along with CIK cells in a ratio of 1:10 in presence
and absence of 200 nM chaetocin for 24 h. The chaetocin
was first solved in DMSO and afterwards diluted within
the corresponding RPMI medium.
The cell suspensions were then treated with Hoechst
33258 staining solution (Thermo Fisher Scientific,
Waltham, USA) for 10 min. 50,000 beads of Flow Cyto-
metry Absolute Count Standard; Full Spectrum; 999,000
particles/ml (Bangs Laboratories Inc., USA) were added
after additional washing. The stained cell solutions were
then applied to the FACS (BD FACS CANTO II, BD Bios-
ciences, Heidelberg, Germany). The program FLOWJO v10
OSX was used on an Apple Mac for data processing.
Statistical analysis
The statistical analysis was performed using Microsoft
Office Excel 2010. Triplicates were used for every assay
to determine the mean and ±SD. The significance was
determined by the use of an unpaired two-sample location
t-test (*=0.05–0.04, **=0.02–0.03, ***=<0.002).
Results
Chaetocin titering
Prior research stated that 24 h exposure of 2–10 nM
chaetocin cause the death of 50% of all tested solid tumor
cell lines [11]. So the first step was a chaetocin tittering
in the range of 0–10 nM with two tumor (A-498, CAKI-2)
and one non-cancerous control cell line (CCD-18co) (see
Figure 1). The results of the MTT assay clearly show that
the cell viability of CCD-18Co non-cancerous cell line is
not affected by the chosen chaetocin concentration. The
ccRCC cell line CAKI-2 shows a small drop in cell viability
to 92% at a concentration of 10 nM chaetocin while the
A-498 tumor cell lines viability drops to 86% at a
chaetocin concentration of 5 nM and even to 77% at a
concentration of 10 nM chaetocin.
Chaetocin titering of ccRCC cell lines
Since the chosen chaetocin concentrations showed a
weaker effect upon the viability of the ccRCC cell lines
than expected, higher concentration in the range from
0–400 nM were chosen for the next chaetocin tittering.
The cell viability was determined after 1 day and 4 days
of incubation, without additional administration of
chaetocin, in order to see if the cytotoxic effect of the
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Figure 2: Cytotoxic effects of chaetocin on cell viability of ccRCC cell lines A-498 (A) and CAKI-2 (B). Both cell lines were incubated
in medium containing 0–400 nM chaetocin and the cell viability was determined after 1 day (red) and after 4 days (blue) by the
use of the MTT assay. Triplicates were used for each sample to determine the mean ±SD. The significance was determined by
the use of t-test (*=0.05–0.04, **=0.02–0.03, ***=<0.002). Cells without chaetocin treatment were used as negative control
while cells treated with a deadly dose of DMSO were used as positive control.
medical agent increases or if the cells are able to regen-
erate (see Figure 2). Figure 2A shows the results of the
chaetocin titering with A-498 cells. The cell viability of the
A-498 cell line already dropped to 67% after one day of
incubation with 10 nM chaetocin compared to A-498 cells
grown in the absence of chaetocin. A further decrease of
the cell viability is observed at a concentration of 50 nM
where only 51% of the cells remain alive. No further signal
of living cells was detected at concentration of 100 nM
and above. The four day incubation of the cell line along
with chaetocin showed quite different results. The cell
viability stays above 90% until a concentration of 100 nm
is reached which still resulted in a cell viability of 63%
and 6% of the cells stayed alive even at a concentration
of 200 nM chaetocin. Figure 2B displays the cell viability
of the CAKI-2 tumor cell line during the chaetocin titering.
The viability stays above 80% until a chaetocin concentra-
tion of 20 nM is reached resulting in a drop to 76% viab-
ility. Even at higher concentrations like 200 nM 55% of
the CAKI cell line were still alive and 8% at 400 nM. After
four days of incubation, the cell viability of the CAKI-2 cell
line is above 90% until it drops to 81% at a concentration
of 50 nM chaetocin. The results for the one day and four
day incubation are quite similar for the concentration
from 10 nM–50 nM but at 100 nM the viability of the
four day incubated cells dropped to 55% and down to
20% at 200 nM.
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Figure 3: Cytotoxic effects of chaetocin on cell viability of non-cancerous cell line CCD-18Co. The cells were incubated in medium
containing 0–400 nM chaetocin and the cell viability was determined after 1 day (red) and after 4 days (blue) by the use of the
MTT assay. Triplicates were used for each sample to determine the mean ±SD. The significance was determined by the use of
t-test (*=0.05–0.04, **=0.02–0.03, ***=<0.002). Cells without chaetocin treatment were used as negative control while cells
treated with a deadly dose of DMSO were used as positive control.
Chaetocin titering of a non-cancerous
cell line
CCD-18Co is a non-cancerous cell line originated from
the human colon. This cell line is used to test the cytotoxic
effects of chaetocin on non-cancerous cells in order to
compare it with the effects on ccRCC cell lines. Figure 3
shows the results of theMTT test for non-cancerous colon
cells that were incubated with different concentrations
of chaetocin. The cell viability stays above 80% until a
concentration of 200 nM is reached. Incubation with
200 nM chaetocin results in the death of 28% while a
concentration of 400 nM kills 91% of the cells when in-
cubated for 24h. Four days of incubation resulted in a
drop of cell viability to 73% after administration of 10 nM
chaetocin. The next drop in cell viability is observed at
100 nM where 66% of the cells were still alive while it
was only 50% for 200 nM of chaetocin. The final concen-
tration of 400 nM resulted in 21% cell viability which is
more than twice the viability of the samples that were
incubated for one day.
Chaetocin titering of generated CIK cells
In order to use chaetocin in combination with CIK cells it
must be ensured that the used chaetocin concentrations
haveminimal or no effects on the viability of the CIK cells.
Figure 4 displays the effects of chaetocin on CIK cells
when incubated up to four days with different concentra-
tions. The cell viability decreased to 91% after one day
incubation with 10 nM chaetocin. The decrease pro-
gresses slowly until a cell viability of 75% is reached at
100 nM and 200 nM. The final concentration of 400 nM
still leaves 67% of the cells viable. After three and four
days of incubation at a concentration of 10 nM chaetocin
71 % of the cells were still alive in both samples. The cell
viability of both samples decreased slowly and steady to
56% at 100 nM. The incubation with 200 nMand 400 nM
show the first difference between the three and four days
of incubation because the cells that were incubated for
three days only show a viability of 22%while the four days
of incubation resulted in a viability of 53%.
Combination therapy
The ccRCC and CIK cells were combined in a ratio of 1:10
and incubated with and without chaetocin for 24 h. A
concentration of 200 nM chaetocin was chosen since it
killed 100% of the A-498 ccRCC cell line while only killing
28% of CCD-18Co and 25% of CIK. The MTT assay can
be used to determine the cytotoxicity of a certain drug on
a single cell line by simply stating howmany cells survived
the treatment. However, the MTT assay cannot be used
to distinguish between two different cell lines when incub-
ated together. In order to determine how many non-can-
cerous and ccRCC cells survived the incubation along
with chaetocin and CIK cells a FACS was used. Forward
scatter (FSC) and side scatter (SSC) were used to identify
and discriminate CIK cells, non-cancerous and ccRCC
cells. The Hoechst 33258 staining solution was used in
order to stain dead cells independent of being cancerous
or non-cancerous to see howmany survive the treatment.
It was only possible to test one non-cancerous and one
ccRCC cell line due to a lack of resources. Figure 5A 1.1
shows the population of CIK cells and A-498 ccRCC cells
after 24 h of incubation in the absence of chaetocin. Both
populations could be discriminated by their SSC and FSC.
Figure 5A 1.2 shows the ratio of dead and living A-498
cells discriminated by Hoechst vs FSC. After the treatment
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Figure 4: Cytotoxic effects of chaetocin on cell viability of generated CIK cells. The cells were incubated in medium containing
0–10 nM chaetocin and the cell viability was determined after 1 day (red), after 3 days (green) and after 4 days (blue) by the use
of the MTT assay. Triplicates were used for each sample to determine the mean ±SD. The significance was determined by the
use of t-test (*=0.05–0.04, **=0.02–0.03, ***=<0.002). Cells without chaetocin treatment were used as negative control while
cells treated with a deadly dose of DMSO were used as positive control.
50.6% of the ccRCC cells were still alive while 45.9 %
died and 3.5% could not be matched to either group.
Figure 5A 2.1 and A 2.2 show an identical experimental
set up but this time the cells were incubated in the pres-
ence of 200 nM chaetocin. After 24 h of incubation along
with chaetocin 56.4% of the ccRCC cells died while only
41.5% stayed alive and 2.1% could not be matched to
either group.
So the population of dead cells increased by 10.5%when
chaetocin was added. Figure 5B 1.1 displays the popula-
tion of CIK cells and CCD non-cancerous cells incubated
together without chaetocin. Figure 5B 1.2 shows the ratio
of dead and living CCD cells after incubation with CIK
cells. After 24 h of incubation only 14% of the non-cancer-
ous cells died while 84.2% stayed alive and 1.8% could
not be matched to either group. The survival rate de-
creases by 12.2% to 68.6% as 200 nM chaetocin were
added.
Discussion
Chaetocin titering of ccRCC,
non-cancerous and CIK cell lines
Previous research stated that a concentration of 2–10 nm
chaetocin caused the death of 50% of all tested solid
tumor cell lines after 24 h of incubation while mostly
sparing the non-cancerous cells [11]. So the first step
was to recreate the conditions of these experiments to
check if such a low concentration is already sufficient to
kill 50% of the ccRCC cell lines. Therefore, two ccRCC and
two non-cancerous cell lines were incubated with
chaetocin concentration in a range of 0–10 nM (Figure 1).
After 24 h of incubation 99% of the CCD cells were still
alive but also 92% of the CAKI 77% of the A-498 ccRCC
cell line. This titering experiment was performed three
times with two different chaetocin stock solutions in order
to exclude the possibility that the used chaetocin is
somehow inactive. Another titering experiment with
higher chaetocin concentration had to be performed since
a concentration of 10 nM was not enough to even kill
50% of the ccRCC cells. A range of 0–400 nM chaetocin
was chosen in order to determine what concentration is
suitable to kill at least 50% of the ccRCC cells while
sparing non-cancerous cells.
The ID50 of chaetocin for A-498 cells was reached at a
concentration of 50 nM while a concentrating of 100 nM
was high enough to kill 100% of all A-498 cells (Figure 2).
The CAKI cell line showed a quite different result since
200 nM chaetocin where necessary to kill 45% of the
ccRCC cell line while even a concentration of 400 nM left
8.3% living cells (Figure 2). Surprisingly the CAKI cells
needed 4 times as much chaetocin as the A-498 cells to
reach the ID50 and the A-498 cells still needed five times
as much chaetocin as previously reported by other re-
search groups. The non-cancerous CCD cells remained
above 80% survival until a concentration of 200 nM
chaetocin was reached, 400 nM still left 9.1% of the cells
intact (Figure 3). The second non-cancerous cell popula-
tion was CIK cells that showed a survival of more than
75% at a concentration of 200 nM and 67% of the cells
were even alive at 400 nM (Figure 4). Even though the
chaetocin concentrations needed to kill the ccRCC cells
were much higher than expected, the effects were
stronger on ccRCC than on non-cancerous cell lines. The
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Figure 5: Results of the FACS analysis of ccRCC (A1, A2) and non-cancerous (B1, B2) cell line treated with CIK cells only (A1,
B1) and CIK cells in combination with 200 nM chaetocin (A2, B2) for 24 h. Population of CIK cells and ccRCC cells weremeasured
by FCS vs SSC. Hoechst 33258 stain and FSC was used to discriminate between living and dead ccRCC cells.
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reasonwhy the CAKI cells survivedmuch higher chaetocin
concentrations than the A-498 cells is still unclear. The
additional 4 days of incubation were performed in order
to test if the cells are able to recover or if the cytotoxic
effect increases along with higher incubation times. The
A-498 cell lines showed recovery since 51% of the ccRCC
cells died at a concentration of 100 nM after 24 h of in-
cubation while 90% of the cells were alive after 4 days
of incubation with the same amount of chaetocin. The
CAKI and CCD cell lines showed different results since
the cells incubated for 4 days showed a higher number
of dead cells than ones incubated for 24 h. 75% of the
CIK cells survived when incubated for 24 h while the
survival dropped to 20% after 3 days but then rapidly in-
creased up to 52% after 4 days of incubation. Due to a
lack of resources only one ccRCC cell line could be subject
to the combination therapy of CIK cells and chaetocin.
Based on theMTT results, the A-498 cell line was chosen
because of its higher susceptibility to chaetocin.
Combination therapy of ccRCC and
non-cancerous cell lines with CIK cells
and chaetocin
The effects of CIK cells in combination with chaetocin on
non-cancerous and ccRCC cell lines was tested although
the cytotoxicity of chaetocin was not proven to be as
strong and as selective as previously reported. Previous
research had shown that a 1:10 ratio of CIK cells and
ccRCC cells usually results in the death of 50% of the
ccRCC cells after 24 h of incubation [8] and our work
showed that 200 nm are sufficient enough to kill up to
100% of the A-498 ccRCC cell line. Based on this data
ccRCC and non-cancerous cell lines were incubated in a
1:10 ratio along with CIK cells and 200 nM of chaetocin
to test if the chaetocin increases the effect of ccRCC cell
destruction along with CIK cells (Figure 5). Again the
cytotoxicity and selectivity of chaetocin were much lower
than expected. The CIK cells alone were able to kill nearly
50% of the ccRCC cells within 24 h of incubation while
only 14% of the non-cancerous cells died. A low number
of non-cancerous cells are usually targeted and destroyed
by CIK cells but the death of 14% of non-cancerous cell
could also be due to the repeated washing and incubation
steps during the cell preparation for the FACS analysis.
Since the addition of 200 nM of chaetocin for 24 h result-
ed in the death of 100% of A-498 ccRCC cells according
to theMTT results it is expected that all ccRCC cell should
die during the incubation with CIK cells and chaetocin.
The results of the FACS analysis state otherwise, the ad-
dition of chaetocin increased the number of dead ccRCC
cells by only 10.5% but also increased the number of non-
cancerous dead cells by 12.2%.
Conclusions
Chaetocin acts by histone lysine methylase inhibition
[12], [13]. It has been shown to be effective in human
non-small cell lung cancer cells and in acutemyelogenous
cells [14], [15]. However, the cytotoxicity of chaetocin at
low concentrations was in our experiments found to be
much weaker than expected. Although identical culture
and incubation methods and concentrations were used,
the determined ID50 was more than 20 times higher than
previously reported [11]. And even though non-cancerous
cells were less affected by chaetocin than the ccRCC cells
during the MTT assay, this could not be achieved in
combination with CIK cells. During the combination ther-
apy the number of dead non-cancerous cells increased
stronger than the number of ccRCC cells while incubated
with chaetocin and CIK cells in comparison to CIK cells
alone. Based on these results chaetocin is not a suitable
agent for treating ccRCC cells solely because the concen-
tration needed to kill a sufficient number of ccRCC cells
also caused the death of at least one fourth of the non-
cancerous cells. As previously mentioned chaetocin accu-
mulates in non-cancerous as well as in ccRCC cells and
creates ROS but only causes the death of ccRCC cells
because they cannot compensate the upcoming ROS
concentrations [4]. It is reasonable that the high concen-
tration of 100–400 nM caused such high ROS concentra-
tions that also a part of the non-cancerous cells could
not compensate by the use of the enzymatic systems. In
addition the accumulation of such high chaetocin
amounts alone might have killed the non-cancerous and
cancerous cells to the same extent. The combination
therapy showed that the addition of chaetocin increased
the death of non-cancerous cells even more than the
death of ccRCC cells and thus chaetocin is also not suit-
able for the combination therapy along with CIK cells.
Nevertheless CIK cells worked exactly like expected. After
24 h of incubation nearly 50% of ccRCC cells were killed
while only 14% of non-cancerous cells died. The anti-
cancer activity along with the high ex vivo replication and
easy generation allows the specific targeting of ccRCC
cells while causing only few deadly side effects on the
non-cancerous cells.
The effects of chaetocin on other cancerous cell lines
could be a subject of future experiments since it would
be interesting to determine if the effects differ depending
on the type of cancer cell. Also future studies should focus
on understanding the exact mechanism of chaetocin’s
assumed anti-cancerous activity.
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